Matti Karvonen Insider Profile
4 Followers
Matti Karvonen, Chief Medical Officer at Faron Pharmaceuticals Oy, holds ― shares in Faron Pharmaceuticals Oy (Ticker: GB:FARN). Most recently, Matti Karvonen Bought 42,735 shares of Faron Pharmaceuticals Oy on Mar 28, 2019 for an estimated value of 30.00K .
Matti Karvonen's Trading History
| FARNFaron Pharmaceuticals Oy | Mar 28, 2019 | Chief Medical Officer | Informative Buy | 30.00K | ― | |||||||||||||||||||||||||||||||||||||||||||
GB:FARN
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Matti Karvonen insider profile FAQ
What is the percentage of profitable transactions made by Matti Karvonen?
The percentage of profitable transactions made by Matti Karvonen is 67%.
What is the average return per transaction made by Matti Karvonen?
The average return per transaction made by Matti Karvonen is 107.70%.
What stocks does Matti Karvonen hold?
Matti Karvonen holds: GB:FARN stocks.
What was Matti Karvonen’s latest transaction?
Matti Karvonen’s latest transaction was an Informative Buy of 30.00K .
What was Matti Karvonen's most profitable transaction?
Matti Karvonen’s most profitable transaction was an Informative Buy of GB:FARN stock on March 28, 2019. The return on the trade was 645.90%.
What is Matti Karvonen's role in Faron Pharmaceuticals Oy?
Matti Karvonen's role in Faron Pharmaceuticals Oy is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
